TODDE, SERGIO CAMILLO
 Distribuzione geografica
Continente #
NA - Nord America 5.337
EU - Europa 2.478
AS - Asia 598
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 2
Totale 8.440
Nazione #
US - Stati Uniti d'America 5.236
IT - Italia 525
DE - Germania 509
SE - Svezia 463
CN - Cina 371
IE - Irlanda 301
UA - Ucraina 222
GB - Regno Unito 173
HK - Hong Kong 117
CA - Canada 101
AT - Austria 59
FI - Finlandia 59
FR - Francia 37
DK - Danimarca 36
VN - Vietnam 32
RU - Federazione Russa 24
IN - India 23
BE - Belgio 20
NL - Olanda 16
SG - Singapore 12
TR - Turchia 12
BG - Bulgaria 10
JP - Giappone 10
PL - Polonia 8
IR - Iran 7
PE - Perù 6
EU - Europa 5
KR - Corea 5
RO - Romania 5
CO - Colombia 3
ES - Italia 3
SA - Arabia Saudita 3
AR - Argentina 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
ET - Etiopia 1
JO - Giordania 1
LT - Lituania 1
ME - Montenegro 1
MU - Mauritius 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
Totale 8.440
Città #
Ann Arbor 1.568
Fairfield 433
Houston 372
Woodbridge 359
Wilmington 324
Chandler 321
Dublin 284
Ashburn 283
Jacksonville 245
Dearborn 194
Frankfurt am Main 189
New York 171
Seattle 164
Cambridge 135
Milan 117
Hong Kong 115
Princeton 112
Nanjing 79
Altamura 59
Vienna 59
Lawrence 49
Lachine 39
Shanghai 39
San Diego 34
Beijing 33
Boardman 28
Shenyang 25
Nürnberg 24
Hebei 23
Toronto 22
Guangzhou 21
Brussels 20
Lissone 20
Tianjin 20
Falls Church 19
Nanchang 19
Andover 18
Changsha 17
Dong Ket 17
Rome 17
Fremont 16
Jiaxing 16
Helsinki 15
Montréal 15
Jinan 14
London 13
Ottawa 13
Kunming 11
Ningbo 11
Edmonton 10
Plovdiv 10
Bologna 9
Auburn Hills 8
Huizen 8
Los Angeles 8
Carate Brianza 7
Mountain View 7
Norwalk 7
Washington 7
Catania 6
Detroit 6
Lima 6
Padova 6
Segrate 6
Taizhou 6
Turin 6
University Park 6
Biassono 5
Chicago 5
Philadelphia 5
Phoenix 5
San Mateo 5
Tokyo 5
Zhengzhou 5
Borgo Valsugana 4
Cardano al Campo 4
Costa Mesa 4
Hangyang 4
Kiev 4
Munich 4
Polska 4
Pune 4
Redmond 4
Tappahannock 4
Amsterdam 3
Bogotá 3
Buffalo 3
Chengdu 3
Clearwater 3
Emmen 3
Florence 3
Genoa 3
Hefei 3
Hounslow 3
Ispra 3
Kilburn 3
Leawood 3
Monza 3
Novara 3
Perugia 3
Totale 6.463
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 361
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 351
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 326
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 294
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 292
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 272
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 252
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 244
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 194
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 194
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 189
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 180
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 170
EANM Guideline on the validation of analytical methods for radiopharmaceuticals 170
Sperimentazione clinica con radiofarmaci 168
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 167
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 167
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 159
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 159
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 158
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 154
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 154
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 151
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 150
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia 150
Quality Control in the Production of Radiopharmaceuticals 145
Rsdiofarmaci marcati con fluoro-18 145
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 143
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 142
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility 141
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 140
Automation of [C-11]acyl chloride syntheses using commercially available C-11-modules 139
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 139
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting 133
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 130
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 129
High yield synthesis of [11C]-acetone through selective quenching of methyl lithium 128
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 126
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 125
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 122
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 122
PET in psychopharmacology 120
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 119
Synthesis of [O-methyl-11c]fluvoxamine-a potential serotonin uptake site radioligand 113
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography [2] 108
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals 105
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 101
A PET follow-up study of recovery after stroke in acute aphasics 89
Classificazione ambientale 84
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 82
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals 78
Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach. 71
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 70
Guidance on current good radiopharmacypractice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective 63
From radiotracer to radiopharmaceutical: a philosophical approach 53
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 46
PET radiopharmacy and automation 44
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 30
EANM guideline on quality risk management for radiopharmaceuticals 22
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals 15
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' 15
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 11
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework 3
Totale 8.817
Categoria #
all - tutte 24.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019382 0 0 0 0 0 0 0 0 0 0 161 221
2019/20201.677 188 104 119 138 168 206 240 111 161 108 110 24
2020/20211.445 59 71 153 160 117 120 140 112 127 136 106 144
2021/20221.021 89 111 168 136 35 59 62 69 49 59 77 107
2022/20231.344 164 387 84 134 100 197 26 78 71 19 57 27
2023/2024985 44 40 56 39 147 310 211 40 85 12 1 0
Totale 8.817